Clinical trial
Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome
NCT07526051 is registered in ClinicalTrials.gov with Foundation University Islamabad as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome
- Lead sponsor
- Foundation University Islamabad
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 20, 2026
- Completion date
- July 15, 2026
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lower cross syndrome